4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001061983-26-000002
EVP, Chief Commercial Officer sold 15,000 shares at $60.28 ($904,200)
- EVP, Chief Commercial Officer acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Callos Andrew · EVP, Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,000 | $23.26 | $348,900 | 65,440 | D |
| 2026-01-05 | Sale : show line 2 in the form 10b5-1 | −15,000 | $60.28 | $904,200 | 50,440 | D |
| Open-market sales · 15,000 sh · avg $60.28 · $904,200 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-05 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) | −15,000 | 99,000 | D |
Loading xslF345X05/form4.xml…